(Press-News.org) (PORTLAND, Ore.) —June 07, 2012—Eleven integrated health systems, with more than 16 million members, have combined de-identified data from their electronic health records to form the largest, most comprehensive private-sector diabetes registry in the nation.
According to a new study published today in the Centers for Disease Control and Prevention's Preventing Chronic Disease, the SUPREME-DM DataLink provides a unique and powerful resource to conduct population-based diabetes research and clinical trials.
"The DataLink will allow us to compare more prevention and treatment strategies with a larger group of patients, which will ultimately prevent more people from getting the disease and improve care for the 25 million Americans who already have it," said Greg Nichols, PhD, lead study author and senior investigator with the Kaiser Permanente Center for Health Research in Portland, Oregon.
Most other registries are smaller and are associated with a single health or hospital system in one region of the country. The United States Department of Veterans Affairs maintains a valuable diabetes research database containing a similar number of patient records, but most of those patients are men, and they are sicker than the general population.
"Our database contains an ethnically and geographically diverse population of women and men who mirror the general population with diabetes. We can follow these patients over time and expect that what happens with our patients will also happen with patients throughout the country," said John Steiner, MD, a co-author and senior director with the Kaiser Permanente Institute for Health Research in Denver, Colorado.
The SUPREME-DM (SUrveillance, PREvention, and ManageEment of Diabetes Mellitus) DataLink includes de-identified health information from nearly 1.1 million people with diabetes in 10 states: California, Colorado, Georgia, Hawaii, Michigan, Minnesota, Oregon, Pennsylvania, Washington, and Wisconsin. Participating health plans include six regions of Kaiser Permanente, Geisinger Health System, Group Health Cooperative, HealthPartners, Henry Ford Health System, and Marshfield Clinic.
The DataLink contains test results, prescription records, hospital and clinic visit information, and vital statistics of more than one million people with diabetes. The project also brings together 33 diabetes researchers with diverse backgrounds, expertise, and interests.
The CDC estimates that 18.8 million people in the United States have been diagnosed with diabetes, and that 7 million more have the disease but have not been diagnosed. Diabetes, which interferes with the body's ability to produce insulin and process glucose, is a major cause of heart disease, stroke, and death. According to the CDC, it is also the leading cause of kidney failure, non-traumatic lower limb amputations, and new cases of blindness in this country. The CDC estimates that in 2007, the medical and indirect costs of diabetes totaled $174 billion.
###
About SUPREME-DM
To start the SUPREME-DM DataLink, researchers included all 15,765,529 health plan members who were enrolled in the 11 participating health plans between January 2005 and December 2009. Of those members, 1,085,947, or 6.9 percent, met the study criteria for diabetes, which included a single diagnosis of diabetes in the hospital or two separate diagnoses made in an outpatient setting; two elevated blood glucose tests conducted on separate occasions; or at least one diabetes drug dispense.
Among the 11 health plans, the percentage of people who met the criteria for diabetes ranged from 4.2 to 12.4 percent. The mean age of patients at registry entry was 55.7 years, and 48.1 percent were women.
The SUPREME-DM DataLink contains inpatient and outpatient health records; comprehensive laboratory test results including blood glucose, hemoglobin, and serum lipid levels; and height and weight measurements. It also contains pharmacy records for more than 90 percent of patients.
The DataLink is part of a larger data-sharing project known as the Virtual Data Warehouse (VDW). The VDW was developed by the HMO Research Network, a consortium of 19 health care delivery organizations that have agreed to standardize datasets from their electronic health records to collaborate on research projects such as this one.
The study was funded by a grant from the Agency for Healthcare Research and Quality. Authors include Gregory A. Nichols, PhD, from the Kaiser Permanente Center for Health Research in Portland, Oregon; Jay Desai, MPH, and Patrick O'Connor, MD, MPH, from HealthPartners Research Foundation in Minneapolis, Minnesota; Jennifer Elston Lafata, PhD, from Henry Ford Health System in Detroit, Michigan, and Virginia Commonwealth University; Jean M. Lawrence, ScD, MPH, MSSA, from Kaiser Permanente in Pasadena, California; Ram Pathak, MD, FACP, from Marshfield Clinic in Marshfield, Wisconsin; Marsha Raebel, PharmD, and John Steiner, MD, from Kaiser Permanente in Denver, Colorado; Robert Reid, MD, PhD, from Group Health Research Institute in Seattle, Washington; Joseph Selby, MD, MPH, from the Patient Centered Outcomes Research Institute in Washington, D.C.; Barbara Silverman, MD, MPH, Maccabi Healthcare Services in Tel Aviv, Israel; WF Stewart, PhD, MPH, from Geisinger Health System in Danville, Pennsylvania; Suma Vupputuri, PhD, from Kaiser Permanente in Atlanta, Georgia, and Beth Waitzfelder, PhD, from Kaiser Permanente in Honolulu, Hawaii.
HMO Research Network
The HMO Research Network includes 19 research centers, each associated with a health care delivery system. Researchers at the centers collaborate on multi-site studies in real-world health care settings across the United States and in Israel. With access to information on more than 16 million ethnically and geographically diverse patients, these researchers are finding solutions for common and rare health problems. Since 1994, the Network has been answering pressing questions about keeping people healthy and delivering effective care.
About the Kaiser Permanente Center for Health Research
The Kaiser Permanente Center for Health Research, founded in 1964, is a nonprofit research institution dedicated to advancing knowledge to improve health. It has research sites in Portland, Ore., Honolulu, Hawaii and Atlanta. Visit www.kpchr.org for more information.
About Kaiser Permanente
Kaiser Permanente is committed to helping shape the future of health care. We are recognized as one of America's leading health care providers and not-for-profit health plans. Founded in 1945, our mission is to provide high-quality, affordable health care services and to improve the health of our members and the communities we serve. We currently serve more than 9 million members in nine states and the District of Columbia. Care for members and patients is focused on their total health and guided by their personal physicians, specialists and team of caregivers. Our expert and caring medical teams are empowered and supported by industry-leading technology advances and tools for health promotion, disease prevention, state-of-the-art care delivery and world-class chronic disease management. Kaiser Permanente is dedicated to care innovations, clinical research, health education and the support of community health. For more information, go to: www.kp.org/newscenter.
11 integrated health systems form largest private-sector diabetes registry in US
Researchers use database of more than 1 million diverse diabetes patients to find better treatment & prevention strategies
2012-06-08
ELSE PRESS RELEASES FROM THIS DATE:
U Alberta finds weakness in armor of killer hospital bacteria
2012-06-08
There's new hope for development of an antibiotic that can put down a lethal bacteria or superbug linked to the deaths of hundreds of hospital patients around the world.
Researchers from the University of Alberta-based Alberta Glycomics Centre found a chink in the molecular armour of the pathogen Acinetobacter baumannii. The bacteria first appeared in the 1970's and in the last decade it developed a resistance to most antibiotics.
U of A microbiologist Mario Feldman identified a mechanism that allows Acinetobacter baumannii to cover its surface with molecules knows ...
Personalizing biologic treatment to individual patients with rheuatoid arthritis is cost-effective
2012-06-08
Berlin, Germany, June 7 2012: Data presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, demonstrates that tailoring biologic treatment to individual patients with rheumatoid arthritis (RA) can reduce total costs by €2,595,557 per 272 patients over 3 years (95 percentile range -€2,983,760 to -€2,211,755), whilst increasing effectiveness by an average of 3.67 quality-adjusted life years (QALYs)*. Cost savings were mostly on drug costs.
The Dutch study, which investigated 272 patients with RA starting adalimumab treatment, measured ...
Treatment with anti-TNFs reduces the risk of cardiovascular events in rheumatoid arthritis
2012-06-08
Berlin, Germany, June 7 2012: Results from a retrospective analysis of contemporary data presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, predict, based on estimates from a multivariate regression model, that the cumulative use of anti-tumour necrosis factor drugs (anti-TNFs) for one, two, or three years is associated with reduced risk of cardiovascular events by 24%, 42% and 56% in patients with rheumatoid arthritis (RA) respectively, compared to not using anti-TNF therapies (adjusting for background use of methotrexate or other ...
Nearly two-thirds of American osteoporotic hip fractures are seen in the extreme elderly
2012-06-08
Berlin, Germany, June 7 2012: A new American study presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, calls for more aggressive management of osteoporosis in the extreme elderly as the true impact of osteoporotic hip fractures in those aged 80 years or older is unveiled.
Via the Nationwide Inpatient Sample (NIS), 4.3 million patients over the age of 65 with osteoporotic hip fractures were studied. Results showed that 67.3% of hip fractures occurred in the extreme elderly, increasing from 172,209 in 1993 to 180,428 in 2008. This ...
Patients taking certolizumab pegol are twice as likely to achievE ACR20 compared to placebo
2012-06-08
Berlin, Germany, June 7 2012: A new Phase III study presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, shows that patients treated with certolizumab pegol (CZP) were twice as likely to meet the primary endpoint of ACR20* response at week 12 than those on placebo: 58% on CZP200mg Q2W; and 51.9% on CZP 400 mg Q4W compared to 24.3% on placebo.
This randomised, placebo controlled, 24 week period of an ongoing Phase III study of 409 patients indicated that more patients treated with both doses of CZP achieved ACR50* and ACR70* response ...
Control of disease activity and biologic treatment increase life expectency in RA patients
2012-06-08
Berlin, Germany, June 7 2012: According to a study presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, patients with rheumatoid arthritis (RA) who are prescribed biologic treatments have a significantly lower mortality risk (adjusted hazard ratio [HR]: 0.61) than those just treated with traditional disease modifying anti-rheumatic drugs (DMARDs).The study also found the mortality was similar irrespective of the method of action of biologics (anti-tumour necrosis factor drugs [anti-TNFs] or rituximab).
Results of the German study ...
Treatment with anti-TNFs can increase the risk of shingles by up to 75 percent
2012-06-08
Berlin, Germany, June 7 2012: Patients with inflammatory rheumatic diseases (IRD) treated with anti-tumour necrosis factor medications (anti-TNFs) have a 75% greater risk of developing herpes zoster, or shingles, than patients treated with traditional disease modifying anti-rheumatic drugs (DMARDs), according to a meta-analysis presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism.
"Anti-TNFs, such as infliximab, adalimumab and etanercept have become the treatment of choice for patients with inflammatory rheumatic diseases who ...
Head-to-head study in RA shows that abatacept has comparable efficacy to adalimumab
2012-06-08
Berlin, Germany, June 7 2012: Data from one of the few head-to-head trials in rheumatoid arthritis (RA) presented today at EULAR 2012, the Annual Congress of the European League Against Rheumatism, demonstrates that at one year, 64.8% of patients receiving abatacept (Orencia) and 63.4% of patients receiving adalimumab (Humira) achieved ACR20*.
The Phase IIIb AMPLE study (Abatacept Versus Adalimumab Comparison in Biologic-Naive RA Subjects with Background Methotrexate) was carried out in 646 biologic-naïve patients with active RA and inadequate response to methotrexate. ...
Experts call for strong regulation and peer review of military and civilian nuclear programs
2012-06-08
All nuclear energy and weapons programs should be independently regulated and subject to rigorous peer review, according to three experts on nuclear policy. Their comments and recommendations are published in an article entitled, "A Safer Nuclear Enterprise," in the June 8 issue of the journal Science.
The authors noted that, despite international diplomatic efforts to prevent the proliferation of nuclear weapons and ensure that nuclear material is protected against theft, there is growing apprehension about terrorists acquiring weapons or nuclear material.
"There is ...
CheapCarInsurance.net Explains Why You Should Purchase Rental Car Insurance
2012-06-08
When you are planning a vacation or a trip and you need to rent a car, one of the most important things that you should consider is whether or not you need to buy rental car insurance. When you search for a car rental company online or in person, most salespeople will tell you that you need insurance, while most web pages will tell you that you do not need it. This couldn't be further from the truth. In reality, purchasing rental car insurance for a few extra dollars per day may be one of the most intelligent things that a person can do for themselves.
CheapCarInsurance.net ...
LAST 30 PRESS RELEASES:
Youngest in class at higher risk of mental health problems
American Heart Association announces new volunteer leaders for 2025-26
Gut microbiota analysis can help catch gestational diabetes
FAU’s Paulina DeVito awarded prestigious NSF Graduate Research Fellowship
Champions for change – Paid time off initiative just made clinical trials participation easier
Fentanyl detection through packaging
Prof. Eran Meshorer elected to EMBO for pioneering work in epigenetics
New 3D glacier visualizations provide insights into a hotter Earth
Creativity across disciplines
Consequences of low Antarctic sea ice
Hear here: How loudness and acoustic cues help us judge where a speaker is facing
A unique method of rare-earth recycling can strengthen the raw material independence of Europe and America
Epilepsy self-management program shows promise to control seizures, improve mood and quality of life
Fat may play an important role in brain metabolism
New study finds no lasting impact of pandemic pet ownership on human well-being
New insights on genetic damage of some chemotherapies could guide future treatments with less harmful side effects
Gut microbes could protect us from toxic ‘forever chemicals’
Novel modelling links sea ice loss to Antarctic ice shelf calving events
Scientists can tell how fast you're aging from a single brain scan
U.S. uterine cancer incidence and mortality rates expected to significantly increase by 2050
Public take the lead in discovery of new exploding star
What are they vaping? Study reveals alarming surge in adolescent vaping of THC, CBD, and synthetic cannabinoids
ECMWF - delivering forecasts over 10 times faster and cutting energy usage by 1000
Brazilian neuroscientist reveals how viral infections transform the brain through microscopic detective work
Turning social fragmentation into action through discovering relatedness
Cheese may really be giving you nightmares, scientists find
Study reveals most common medical emergencies in schools
Breathable yet protective: Next-gen medical textiles with micro/nano networks
Frequency-engineered MXene supercapacitors enable efficient pulse charging in TENG–SC hybrid systems
Developed an AI-based classification system for facial pigmented lesions
[Press-News.org] 11 integrated health systems form largest private-sector diabetes registry in USResearchers use database of more than 1 million diverse diabetes patients to find better treatment & prevention strategies